TheraXyte BioScience
PrivateLast Round
Seed
Jul 11, 2022
Total Funding Raised
$10M
Company Overview
TheraXyte BioScience operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Seed round in July 2022.
TheraXyte BioScience is a biotechnology company that develops an extracellular vesicle (EV)-mediated drug delivery platform and EV-based novel therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TheraXyte BioScience Comparables
Compare TheraXyte BioScience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evox Therapeutics | 81% | |
| ILIAS Biologics Inc. | 81% | |
| EXO Biologics | 80% |
For institutional investors. Book with your work email.
TheraXyte BioScience Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
Monthly visitors increased 2249% MoM, from 37 to 869.
- Jul 11, 2022
$10M round led by NHH Venture Fund, L.P.
For institutional investors. Book with your work email.
TheraXyte BioScience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TheraXyte BioScience's valuation, stock price, and market status.
Is TheraXyte BioScience a public or private company?
TheraXyte BioScience is a private company.
What is the current stock price of TheraXyte BioScience?
TheraXyte BioScience is a private company, so its shares have no public market price. Caplight tracks TheraXyte BioScience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TheraXyte BioScience worth (valuation)?
Valuation information for TheraXyte BioScience is not publicly available.
Can I buy TheraXyte BioScience stock?
TheraXyte BioScience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TheraXyte BioScience's last funding round?
TheraXyte BioScience's most recent funding round was Seed on July 11, 2022.
Who are the main investors in TheraXyte BioScience?
Investor information for TheraXyte BioScience is not publicly disclosed.
Will TheraXyte BioScience IPO soon?
No public IPO plans have been announced for TheraXyte BioScience.
How can I track TheraXyte BioScience secondary market activity?
Caplight tracks bids, offers, and trades in TheraXyte BioScience's shares on secondary markets.